Bioequivalence and Bioavailability Forum 04:22 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Body surface area [Regulatives / Guidelines]

posted by Rock - India, 2018-02-12 09:47  - Posting: # 18407
Views: 732

Dear Members
Please let me know, if body surface area (BSA) needs to be used for dose calculation in case of non-NTI drugs and in healthy subjects.

Also, confirm if an infusion study with long washout period which anticipated to significant change in weight, results in different dosages across the periods will require dose normalization?

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,154 posts in 4,080 threads, 1,308 registered users;
online 15 (0 registered, 15 guests [including 5 identified bots]).

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed